Literature DB >> 28990973

The Issue of Gadolinium Retained in Tissues: Insights on the Role of Metal Complex Stability by Comparing Metal Uptake in Murine Tissues Upon the Concomitant Administration of Lanthanum- and Gadolinium-Diethylentriamminopentaacetate.

Enza Di Gregorio, Giuseppe Ferrauto, Chiara Furlan, Stefania Lanzardo, Raffaele Nuzzi, Eliana Gianolio, Silvio Aime.   

Abstract

OBJECTIVES: The aim of the study was to explore the role of the stability of metal complexes in the processes that lead to the metal retention in the brain and other tissues of mice administered with lanthanides-based contrast agents. This issue was tackled by the simultaneous injection of gadolinium (Gd)-diethylentriamminopentaacetate (DTPA) and lanthanum-DTPA, which have the same charge and structure but differ in their thermodynamic stability by 3 orders of magnitude.
MATERIALS AND METHODS: A total of 20 healthy BALB/c mice were administered by a single intravenous injection with a dose consisting of 0.6 mmol La-DTPA/kg and 0.6 mmol Gd-DTPA/kg. Then the animals were killed at different time points: 4, 24, 48, and 96 hours (5 mice each group).In an additional protocol, 5 mice were administered with 9 doses of 0.3 mmol La-DTPA/kg and 0.3 mmol of Gd-DTPA/kg every 2 days over a period of 3 weeks. The sacrifice time was set to 3 weeks after the last administration. After sacrifice, the Gd and La content in liver, spleen, kidney, muscle, cerebrum, cerebellum, bone, eye, skin, blood, and urine was determined by inductively coupled plasma-mass spectrometry.
RESULTS: A general decrease in the content of both the lanthanides was observed upon delaying the sacrifice time. At relatively short times after the injection (up to 96 hours), in the spleen, kidney, muscle, skin, and eye, almost the same content of La and Gd was detected, whereas in the cerebrum, cerebellum, bones, and liver, the amount of retained La decreased much slower than that of Gd, yielding a progressive increase in La/Gd ratio. The amount of retained La in the various tissues 21 days after the last of 9 administrations of La-DTPA and Gd-DTPA was always significantly higher than that of Gd. The concentration of both La and Gd decreased rapidly both in blood and in urine samples. DISCUSSION: The departure from the 1:1 ratio in the amounts of La and Gd determined in the investigated tissues has been used to gain information on the role of the complex stability and "wash-out" kinetics. The behavior of the less s` La-DTPA highlights processes occurring for Gd-DTPA at a slower rate.The herein obtained results support the view that most of the La/Gd retained in the brain arises from the intact chelate that has extravasated immediately after the intravenous administration. Long-term deposition of metal ions from internal reservoirs seems particularly relevant for liver and spleen.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 28990973     DOI: 10.1097/RLI.0000000000000423

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  9 in total

Review 1.  The biological fate of gadolinium-based MRI contrast agents: a call to action for bioinorganic chemists.

Authors:  Mariane Le Fur; Peter Caravan
Journal:  Metallomics       Date:  2019-02-20       Impact factor: 4.526

2.  Yttrium-86 Is a Positron Emitting Surrogate of Gadolinium for Noninvasive Quantification of Whole-Body Distribution of Gadolinium-Based Contrast Agents.

Authors:  Mariane Le Fur; Nicholas J Rotile; Carlos Correcher; Veronica Clavijo Jordan; Alana W Ross; Ciprian Catana; Peter Caravan
Journal:  Angew Chem Int Ed Engl       Date:  2019-12-04       Impact factor: 15.336

Review 3.  Methodological Aspects for Preclinical Evaluation of Gadolinium Presence in Brain Tissue: Critical Appraisal and Suggestions for Harmonization-A Joint Initiative.

Authors:  Philippe Robert; Thomas Frenzel; Cécile Factor; Gregor Jost; Marlène Rasschaert; Gunnar Schuetz; Nathalie Fretellier; Janina Boyken; Jean-Marc Idée; Hubertus Pietsch
Journal:  Invest Radiol       Date:  2018-09       Impact factor: 6.016

4.  Nanosized T1 MRI Contrast Agent Based on a Polyamidoamine as Multidentate Gd Ligand.

Authors:  Paolo Arosio; Davide Cicolari; Amedea Manfredi; Francesco Orsini; Alessandro Lascialfari; Elisabetta Ranucci; Paolo Ferruti; Daniela Maggioni
Journal:  Molecules       Date:  2021-12-28       Impact factor: 4.411

Review 5.  Gadolinium: pharmacokinetics and toxicity in humans and laboratory animals following contrast agent administration.

Authors:  Julie Davies; Petra Siebenhandl-Wolff; Francois Tranquart; Paul Jones; Paul Evans
Journal:  Arch Toxicol       Date:  2022-01-08       Impact factor: 5.153

6.  Effects of chemical forms of gadolinium on the spleen in mice after single intravenous administration.

Authors:  Ryosuke Nakamura; Yasukazu Takanezawa; Yuka Ohshiro; Shimpei Uraguchi; Masako Kiyono
Journal:  Biochem Biophys Rep       Date:  2022-01-28

Review 7.  Gadolinium Retention: A Research Roadmap from the 2018 NIH/ACR/RSNA Workshop on Gadolinium Chelates.

Authors:  Robert J McDonald; Deborah Levine; Jeffrey Weinreb; Emanuel Kanal; Matthew S Davenport; James H Ellis; Paula M Jacobs; Robert E Lenkinski; Kenneth R Maravilla; Martin R Prince; Howard A Rowley; Michael F Tweedle; Herbert Y Kressel
Journal:  Radiology       Date:  2018-09-11       Impact factor: 11.105

8.  LDL mediated delivery of Paclitaxel and MRI imaging probes for personalized medicine applications.

Authors:  Sahar Rakhshan; Diego Alberti; Rachele Stefania; Valeria Bitonto; Simonetta Geninatti Crich
Journal:  J Nanobiotechnology       Date:  2021-07-13       Impact factor: 10.435

9.  Long-Term Evaluation of Gadolinium Retention in Rat Brain After Single Injection of a Clinically Relevant Dose of Gadolinium-Based Contrast Agents.

Authors:  Izabela Strzeminska; Cécile Factor; Philippe Robert; Anne-Laure Grindel; Pierre-Olivier Comby; Joanna Szpunar; Claire Corot; Ryszard Lobinski
Journal:  Invest Radiol       Date:  2020-03       Impact factor: 10.065

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.